Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
20/07/2026 11:51
BRIEF-Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval July 20 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS:
EMCURE PHARMACEUTICALS LTD- TO EXPAND USE OF POVIZTRA FOR MASH INDICATION FOLLOWING CDSCO APPROVAL
Source text: ID:nnAZN4T8VL0
Further company coverage: EMCU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees